Macro market indicators
One of our preferred market valuation indicators is the CAPE model derived from macroeconomic fundamentals.
The basic idea is that lower levels of interest rates raise the market multiple (cashflows discounted at a lower rate should raise the NPV of those cashflows, all else equal) and that changes (shifts lower) in the interest rate, reflecting lower growth expectations, should lower the market multiple.
Restated, we distinguish between levels and changes in levels. Conversely higher rates are bad for market multiples, but if rates are going up because growth is robust, than that is usually quite supportive to higher multiples.
Now the “natural” rate, called R*, is just a low frequency measure of the actual interest rate. Below is a graph of the potential output growth rate, and these various natural rates, including our predicted R*. You can see there is some sort of relationship between them.
And the exact relationship we use is specified by a 3rd order polynomial regression to those growth forecasts. These outputs are shown below. Give us a plausible forecast of growth, and we can calculate a plausible R*.
In our model we also control for the effect on inflation, which is an interest side note, but not the point of this note. However, it plays a role, and we account for it.
So, recall, we’ve wanted to forecast the interest rate used in our model, which we will now use as part of the model to forecast the CAPE ratio. Putting this mix of potential growth, levels and changes in natural rates, and inflation, we can create the below model, and we find all of our relationships have the right sign and generally expected magnitudes.
Based on this mix of potential growth, levels and changes in natural rates, and inflation, we can solve for the implied CAPE ratio.
That works out to be ~25.6x, on a sustainable basis, versus 37.86 at current.
Now, we’ve not been quite so worried about this valuation signal, but, with the Fed starting to signal a taper, it becomes, to our mind, more relevant.
We’ve got Jackson Hole kicking off from Friday across the weekend, and we think it reasonable odds that the Fed uses the opportunity to lay the ground work on a prospective taper.
We see today that secular growth narrative plays, like tech, which do well with low rates, are very strong, suggesting that the market sees good odds of a benign outcome. Understandable, but risky, to us. Likewise commodity stocks, which have done well over the past few days (iron ore, oil, most other commodities, all bouncing) would be vulnerable in that scenario.
Today, we also saw COVID case rates hit over 900 in NSW. These numbers appear to have good momentum, and are still well explained by an exponentially fitted curve. In other words, it doesn’t appear that the peak is in.
But many of the COVID recovery plays (SGR, QAN, FLT, SCG, WEB) are trading as if it is. Arguably, this is due to the increasing acceptance of COVID passports. But in the interim, this is a dangerous game of trading off the future (which likely doesn’t have COVID) when there’s clear evidence of things getting worse, at the margin.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.